Cargando…
Attenuation of CCl(4)-Induced Hepatic Fibrosis in Mice by Vaccinating against TGF-β1
Transforming growth factor β1 (TGF-β1) is the pivotal pro-fibrogenic cytokine in hepatic fibrosis. Reducing the over-produced expression of TGF-β1 or blocking its signaling pathways is considered to be a promising therapeutic strategy for hepatic fibrosis. In this study, we evaluated the feasibility...
Autores principales: | Fan, Xiaobao, Zhang, Qiannan, Li, Shuang, Lv, Yifei, Su, Houqiang, Jiang, Huiping, Hao, Zhiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859579/ https://www.ncbi.nlm.nih.gov/pubmed/24349218 http://dx.doi.org/10.1371/journal.pone.0082190 |
Ejemplares similares
-
The polysaccharides from Grifola frondosa attenuate CCl(4)-induced hepatic fibrosis in rats via the TGF-β/Smad signaling pathway
por: Li, Chao, et al.
Publicado: (2019) -
Ivermectin Attenuates CCl(4)-Induced Liver Fibrosis in Mice by Suppressing Hepatic Stellate Cell Activation
por: Ying, Hanglu, et al.
Publicado: (2022) -
Schisandrin B attenuates CCl(4)-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways
por: Chen, Qingshan, et al.
Publicado: (2017) -
Bergenin Attenuates Hepatic Fibrosis by Regulating Autophagy Mediated by the PPAR-γ/TGF-β Pathway
por: Xia, Yujing, et al.
Publicado: (2020) -
Neoagarooligosaccharide Protects against Hepatic Fibrosis via Inhibition of TGF-β/Smad Signaling Pathway
por: Yang, Ji Hye, et al.
Publicado: (2021)